CHAVON WILLIS: Open Payments
NPI 1346841350 · BEACHWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,179 in 134 payments from 17 companies in 2025. Trend: 2023 $2,302 · 2024 $2,399 · 2025 $2,179
Food & beverage: $2,178Education: $1
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 25 | $470 |
| Vanda Pharmaceuticals Inc. | 18 | $345 |
| Alkermes, Inc. | 13 | $195 |
| Neos Therapeutics, LP | 9 | $173 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $162 |
| Collegium Pharmaceutical, Inc. | 18 | $162 |
| ABBVIE INC. | 9 | $154 |
| Lundbeck LLC | 5 | $102 |
| Corium, LLC | 5 | $80 |
| E.R. Squibb & Sons, L.L.C. | 5 | $77 |
Products named: REXULTI, HETLIOZ, Adzenys XR-ODT, LYBALVI, CAPLYTA, Jornay PM, VRAYLAR, FANAPT.
Industry payments across OH — which companies pay providers there.
